Search Results

Predictive Ability of SVS WIfI Classification System Studied in First-Time Lower Extremity Revascularizations

March 22, 2017—Marc L. Schermerhorn, MD, led an investigation of the predictive ability of the Society for Vascular Surgery (SVS) Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations. The findings were published by Jeremy D. Darling, BA, et al in Journal of Vascular Surgery (JVS; 2017;65:695–704).

National Inpatient Sample Used to Evaluate Impact of TEVAR on Ruptured TAA Management and Outcomes

August 9, 2017—Marc L. Schermerhorn, MD, led a study to assess national trends in the use of thoracic endovascular aortic repair (TEVAR) for the treatment of ruptured thoracic aortic aneurysms (rTAAs) and to determine its impact on perioperative outcomes. The findings were published by Klaas H.J. Ultee, BSc, et al in Journal of Vascular Surgery (2017;66:343–352).

Results Published From TCAR Surveillance Project

December 18, 2019—Silk Road Medical, Inc. announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing TCAR and transfemoral carotid artery stenting (TF-CAS) have been published by Marc L. Schermerhorn, MD, et al in Journal of the American Medical Association (JAMA) (2019;322:2313–2322).

Study Compares Long-Term Outcomes of EVAR and Open Repair for AAA in the Medicare Population

July 23, 2015—Compared to open repair, endovascular aneurysm repair (EVAR) of abdominal aortic aneurysm (AAA) was associated with a substantial early survival advantage that gradually decreased over time, according to a study published by Marc L. Schermerhorn, MD, et al in The New England Journal of Medicine (NEJM; 2015;373:328–333). The National Institutes of Health funded the study.

VQI Data Show Improved Outcomes of Transfemoral CAS With Better Stratification of Preprocedural Symptoms

June 24, 2021—The Society for Vascular Surgery (SVS) announced the publication of an article suggesting that further stratification according to preprocedural symptoms in patients undergoing transfemoral carotid artery stenting (TFCAS) improves the preoperative risk assessment.

Silk Road Medical’s Enroute TCAR System Approved for Expanded Indication of Standard-Risk Patients

May 2, 2022—Silk Road Medical, Inc. announced that the FDA approved expanded indications for the company’s Enroute stent for transcarotid artery revascularization (TCAR) to include patients at standard risk for adverse events from carotid endarterectomy (CEA).

Silk Road Medical Enroute System Will Be Evaluated in Postmarket ROADSTER 3 Study of TCAR for Standard-Risk Patients

June 15, 2022—Silk Road Medical, Inc. announced a prospective study to evaluate the company’s TCAR system for transcarotid artery revascularization in the treatment of standard surgical risk patients with carotid artery disease.

Silk Road Medical’s Enroute System for TCAR Evaluated in Standard Surgical Risk Patients

August 18, 2021—Silk Road Medical, Inc. announced results from an independent analysis of standard surgical risk patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularization (TCAR) for atherosclerotic carotid disease.

Silk Road Medical Begins ROADSTER 3 Postapproval Study of TCAR System in Patients at Standard Surgical Risk

September 7, 2022—Silk Road Medical, Inc. announced enrollment of the first patient in the ROADSTER 3 postapproval study of the company’s system for transcarotid artery revascularization (TCAR) of patients at standard surgical risk with carotid artery disease in real-world treatment.

Outcomes Reported From TCAR Surveillance Project Studying TCAR Versus CEA

September 21, 2020—Silk Road Medical, Inc. announced that positive results from the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project comparing TCAR with carotid endarterectomy (CEA) were published online ahead of print in Annals of Surgery by Mahmoud B. Malas, MD, et al.

Study Examines Nationwide Trends in Aortic Aneurysm Admissions and Repairs

January 31, 2025—In a multicenter, retrospective review of patients admitted with intact and ruptured abdominal aortic aneurysms (AAAs), thoracic aortic aneurysms (TAAs), and thoracoabdominal aortic aneurysms (TAAAs), Conroy et al found that use of endovascular and complex endovascular techniques increased over the past 2 decades, surpassing open repair, and both intact AAA repairs and ruptured AAA admissions significantly decreased.

CAS Compared to CEA for Risk of Stroke and Death

December 13, 2010—The Society for Vascular Surgery announced that Marc L. Schemerhorn, MD, et al reported findings from an evaluation of mortality and stroke following carotid artery stenting (CAS) versus carotid endarterectomy (CEA) stratified by medical high-risk criteria. The study was published in the Journal of Vascular Surgery (2010;52:1497–1504).